Correction to “P90RSK and Nrf2 Activation via MEK1/2‐ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6‐Hydroxydopamine‐Induced Apoptotic Death in SH‐SY5Y Cells”
Abstract
X.-B. Meng, G.-B. Sun, M. Wang, J. Sun, M. Qin, and X.-B. Sun, “P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells,” Evidence-Based Complementary and Alternative Medicine, 2013, 971712, https://doi.org/10.1155/2013/971712. In the article, there is an error in Figure 3a. The incorrect panel for sole NGR2 treatment was selected during manuscript preparation, and the correct Figure 3 is shown below. We apologize for this error.
Fields of Study & Subjects
Ginseng Biological Effects and Applications
Genomics
phytochemicals
and oxidative stress
Parkinson's Disease Mechanisms and Treatments
Publication details
- Journal / source
- Evidence-based Complementary and Alternative Medicine
- Volume
- 2026
- Issue
- 1
- Pages
- 9810324–9810324
- Publication date
- 1 January 2026
- Language
- EN